Assessment of Genital Morphology and Sexual Function in Women with Systemic Sclerosis: A Case–Control Study

Öz

Objective: This study evaluates genital tract involvement and sexual function in women with SSc and examine their relationship with gynecological findings. Material and Methods: This case–control study included 36 women with SSc and 72 age-matched healthy controls (HC). All participants underwent standardized gynecological examinations. Sexual function was evaluated with the Female Sexual Function Index (FSFI), quality of life with the Short Form-36 (SF-36), and pelvic floor function with the Pelvic Floor Impact Questionnaire–Short Form 7 (PFIQ-7). In the SSc group, the Scleroderma Health Assessment Questionnaire (SHAQ) was additionally applied to explore associations between disease activity and sexual dysfunction. Results: Women with systemic sclerosis (SSc) had a significantly smaller uterine size and narrower introital width compared with the control group (p < 0.001). Bladder neck mobility was observed more frequently in controls (p = 0.019). Natural menopause occurred at an earlier age in the SSc group (p = 0.044). No significant differences were found between the groups in sexual function, quality of life, or pelvic floor impact. Conclusions: Women with SSc exhibit significant genital structural changes; however, these do not always adversely affect sexual function or overall genital health.

Anahtar Kelimeler

• Systemic Sclerosis
• Scleroderma
• Sexual Dysfunction
• Gynecology

Kaynakça

1. Ingegnoli F, Ughi N, Mihai C. Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis. Best Pract Res Clin Rheumatol 2018;32(2):223-40. google scholar
2. Lazzaroni MG, Crisafulli F, Moschetti L, Semeraro P, Cunha AR, Neto A, et al. Reproductive issues and pregnancy implications in systemic sclerosis. Clin Rev Allergy Immunol 2023;64(3):321-42. google scholar
3. Minopoulou I, Pyrgidis N, Tishukov M, Sokolakis I, Baniotopoulos P, Kefas A, et al. Sexual dysfunction in women with systemic autoimmune rheumatic disorders: a systematic review and meta-analysis. Rheumatology (Oxford) 2023;62(3):1021-30. google scholar
4. Schouffoer AA, van der Marel J, Ter Kuile MM, Weijenborg PT, Voskuyl A, Vliet Vlieland CW, et al. Impaired sexual function in women with systemic sclerosis: a cross-sectional study. Arthritis Rheum 2009;61(11):1601-8. google scholar
5. Lazzaroni MG, Moschetti L, Pedretti E, Andreoli L, Ramazzotto F, Zatti S, et al. The impact of systemic sclerosis on women’s health evaluated with an ad hoc-developed patient- reported questionnaire. J Scleroderma Relat Disord 2025;10(3):606-15. google scholar
6. Jutiviboonsuk A, Salang L, Eamudomkarn N, Mahakkanukrauh A, Suwannaroj S, Foocharoen C. Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis. Clin Rheumatol 2021;40(6):2267-75. google scholar
7. Dai L, Xu D, Li X, Huang S, Duan X, Zheng A, et al. Reproductive health in female patients with systemic sclerosis: a cross-sectional study. Rheumatology (Oxford) 2024;63(7):1911-6. google scholar
8. Bhadauria S, Moser DK, Clements PJ, Singh RR, Lachenbruch PA, Pitkin RM, et al. Genital tract abnormalities and female sexual function impairment in systemic sclerosis. Am J Obstet Gynecol 1995;172(2 Pt 1):580-7. google scholar

9. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013;72(11):1747-55. google scholar
10. Hamoda H, Sharma A. Premature ovarian insufficiency, early menopause, and induced menopause. Best Pract Res Clin Endocrinol Metab 2024;38(1):101823. google scholar
11. Practice Committee of the American Society for Reproductive Medicine. Definition of infertility: A committee opinion. Fertil Steril 2023;120(6):1170. google scholar
12. Haylen BT, Vu D, Wong A. Surgical anatomy of the vaginal introitus. Neurourol Urodyn 2022;41:1240-7. google scholar
13. D’Alessandro G, Palmieri S, Cola A, Barba M, Manodoro S, Frigerio M. Clinical and urodynamic predictors of Q-tip test urethral hypermobility. Minerva Obstet Gynecol 2022;74(2):155-60. google scholar
14. Nevskaya T, Baron M, Pope JE; Canadian Scleroderma Research Group. Predictive value of European scleroderma group activity index in an early scleroderma cohort. Rheumatology (Oxford) 2017;56(7):1111-22. google scholar
15. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 2003;30:167-78. google scholar
16. Johnson SR, Hawker GA, Davis AM. The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties. Arthritis Rheum 2005;53(2):256-62. google scholar
17. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20(11):1892-6. google scholar
18. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83. google scholar
19. Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The female sexual distress scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 2002;28(4):317-30. google scholar
20. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The female sexual function index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26(2):191-208. google scholar
21. Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 2005;193(1):103-13. google scholar
22. Levis B, Hudson M, Knafo R, Baron M, Nielson WR, Hill M, et al. Rates and correlates of sexual activity and impairment among women with systemic sclerosis. Arthritis Care Res (Hoboken) 2012;64(3):340-50. google scholar
23. Crisafulli F, Lazzaroni MG, Nalli C, Orabona R, Franceschini F, Tincani A. Reproductive health in scleroderma, vasculitis, and sjögren syndrome. J Clin Rheumatol 2024;30(7 Suppl 1):S49-55. google scholar
24. Teresiński L, Sipak O, Rył A, Masiuk M, Rotter I, Ratajczak W, et al. Assessment of morphological changes and steroid receptors in the uteri of postmenopausal women. Histol Histopathol 2019;34(6):631-44. google scholar
25. Yang JL, Hodara E, Sriprasert I, Shoupe D, Stanczyk FZ. Estrogen deficiency in the menopause and the role of hormone therapy: integrating the findings of basic science research with clinical trials. Menopause 2024;31(10):926-39. google scholar
26. Pecher AC, Henes JC, Demin A, Staufenberg EM, Henes M. Ovarian reserve alteration in premenopausal women with systemic sclerosis. Rheumatol Int 2024;44(12):3087-92. google scholar
27. The NAMS 2020 genitourinary syndrome of menopause position statement editorial panel. The 2020 genitourinary syndrome of menopause position statement of the North American Menopause Society. Menopause 2020;27(9):976-92. google scholar
28. Brotto L, Atallah S, Johnson-Agbakwu C, Rosenbaum T, Abdo C, Byers ES, et al. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med 2016;13(4):538-71. google scholar